Dr Vadim Klyushnichenko | Vice President Of Pharmaceutical Development And Quality
Calibr, a division of Scripps Research

Dr Vadim Klyushnichenko, Vice President Of Pharmaceutical Development And Quality, Calibr, a division of Scripps Research

Vadim Klyushnichenko, PhD serves as VP Pharmaceutical Development and Quality at California Institute for Biomedical Research from April 2016. He is responsible for CMO/CRO management, process development, GMP manufacturing, quality assurance and supply chain of the Calibr clinical product portfolio, which includes novel and reformulated small molecules, engineered peptides and proteins, and novel switchable CAR-T cell platform to treat cancer. 

Dr.Klyushnichenko has over 20 years of experience in Bio/Pharmaceutical Development and Manufacturing.  His Drug Delivery experience includes formulation of proteins, peptides and small molecules in micro-crystals, micro- and nano-particles, liposomes, degradable matrixes, as well as the development of controlled-release systems and devices for oral, injectable, implantable and pulmonary delivery.

Vadim has developed his growing managerial and scientific responsibilities working as VP of Drug Development at Paragon BioServices, Terapio Corporation, and Coldstream Laboratories Inc., Lab Head/Principal Scientist at Wyeth BioPharma, Sr.Scientist at Baxter, Altus and Aventis. 

Vadim has received his B.S. in Physics from Moscow Institute of Physics and Technology (FizTech), Ph.D. in Chemistry from Russian Academy of Sciences, and continued his postdoctoral research in Germany and Canada. He is a Professional Supply Chain Manager (APICS) and holds a Certificate of Special Studies (CSS) in Administration and Management from Harvard University. 

Appearances:



December 4 - Main Congress Day 2 @ 11:30

Interactive Roundtables - Click to View

Interactive discussions with like-minded peers tackling the similar challenges in vaccine, antibody and immunotherapy development (Roundtables run twice each for 45mins, select two options)

Best practices for outsourcing manufacture of biologics through CMOs

last published: 17/Sep/19 10:45 GMT

back to speakers

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156

oliver.breed@terrapinn.com


To speak:
Lauren Sheppard
+44 (0)207 092 1211

lauren.sheppard@terrapinn.com